S&P 500
(-0.88%) 4 967.23 points
Dow Jones
(0.56%) 37 986 points
Nasdaq
(-2.05%) 15 282 points
Oil
(0.12%) $83.24
Gas
(0.46%) $1.760
Gold
(-0.29%) $2 406.70
Silver
(-0.34%) $28.75
Platinum
(-0.05%) $943.30
USD/EUR
(-0.12%) $0.938
USD/NOK
(-0.28%) $11.01
USD/GBP
(0.52%) $0.808
USD/RUB
(-0.74%) $93.20

Actualizaciones en tiempo real para Response Genetics, Inc [RGDXQ]

Bolsa: OTC Sector: Healthcare Industria: Diagnostics & Research
Última actualización15 may 2023 @ 12:32

0.00% $ 0.0000010

Live Chart Being Loaded With Signals

Commentary (15 may 2023 @ 12:32):

Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally...

Stats
Volumen de hoy 77 000.00
Volumen promedio 0.00
Capitalización de mercado 116.00
EPS $-0.108 ( 2015-03-31 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 0
ATR14 $0 (0.00%)

Volumen Correlación

Largo: -0.48 (neutral)
Corto: 0.00 (neutral)
Signal:(51.968) Neutral

Response Genetics, Inc Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Response Genetics, Inc Correlación - Moneda/Commodity

The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )

Response Genetics, Inc Finanzas

Annual 2015
Ingresos: $18.04M
Beneficio Bruto: $3.94M (21.85 %)
EPS: $-0.521
Q1 2015
Ingresos: $3.79M
Beneficio Bruto: $1.48M (38.94 %)
EPS: $-0.100
Q4 2014
Ingresos: $4.08M
Beneficio Bruto: $1.63M (40.07 %)
EPS: $-0.0900
Q3 2014
Ingresos: $4.46M
Beneficio Bruto: $1.92M (43.05 %)
EPS: $-0.0900

Financial Reports:

No articles found.

Response Genetics, Inc

Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally. The company offers tests for measuring predictive factors for therapy response in tumor tissue samples. It provides testing services for non-small cell lung cancer, colorectal cancer, gastric and gastroesophageal cancer, melanoma and thyroid cancer, breast cancer, and glioma through its ResponseDX: Lung, ResponseDX: Colon, ResponseDX: Gastric, ResponseDX: Melanoma, ResponseDX: Thyroid, ResponseDX: Breast, ResponseDX: Glioma, and ResponseDX: Tissue of Origin test suites. The company also develops tests for other tumor types; and provides technical component and professional component testing services. It serves community based oncologists, pathologists, physician offices, hospitals, and pharmaceutical companies through its sales force. The company was formerly known as Bio Type, Inc. and changed its name to Response Genetics, Inc. in August 2000. Response Genetics, Inc. was founded in 1999 and is headquartered in Los Angeles, California.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico